In 4 studies (Table 1), the local and systemic levels of neuropeptides namely CGRP, substance P, neuropeptide Y, neurokinin, and bradykinin side were higher in CRPS patients in comparison to controls or the contra-lateral healthy side [13,22,25,64]. This evidence concerns the gene KNG1 and complex regional pain syndrome.